SG Americas Securities
ORIC icon

SG Americas Securities’s Oric Pharmaceuticals ORIC Stock Holding History

SG Americas Securities’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$564K Buy
52,089
+35,996
+224% +$326K ﹤0.01% 2245
2026
Q1 		$204K Sell
16,093
-24,923
-61% -$283K ﹤0.01% 2631
2025
Q4 		$336K Buy
41,016
+22,993
+128% +$265K ﹤0.01% 2701
2025
Q3 		$216K Buy
+18,023
New +$190K ﹤0.01% 2710
2025
Q2 		– Sell
-19,915
Closed -$111K – 3413
2025
Q1 		$111K Sell
19,915
-46,449
-70% -$406K ﹤0.01% 2966
2024
Q4 		$536K Sell
66,364
-3,256
-5% -$29.9K ﹤0.01% 1272
2024
Q3 		$714K Buy
+69,620
New +$688K ﹤0.01% 1368
2023
Q3 		– Sell
-23,150
Closed -$180K – 3213
2023
Q2 		$180K Buy
+23,150
New +$131K ﹤0.01% 1839
2022
Q1 		– Sell
-13,650
Closed -$201K – 3313
2021
Q4 		$201K Sell
13,650
-11,585
-46% -$181K ﹤0.01% 2662
2021
Q3 		$528K Buy
+25,235
New +$512K ﹤0.01% 2448
2021
Q2 		– Sell
-5,695
Closed -$140K – 3130
2021
Q1 		$140K Buy
+5,695
New +$180K ﹤0.01% 2896
2020
Q4 		– Sell
-91,997
Closed -$2.3M – 3435
2020
Q3 		$2.3M Buy
91,997
+69,520
+309% +$1.65M 0.01% 664
2020
Q2 		$758K Buy
+22,477
New +$717K 0.01% 1688

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SG Americas Securities's ORIC Position: Q2 2026 in Review

SG Americas Securities increased its Oric Pharmaceuticals (ORIC) stake by 224% in Q2 2026, buying an estimated $326K and bringing the position to 52,089 shares worth $564K. The position accounts for ﹤0.01% of the portfolio, ranked #2245.

SG Americas Securities first reported a position in ORIC in Q2 2020 and has held it in 13 quarters since. The position peaked at $2.3M in Q3 2020. 181 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • SG Americas Securities held 52,089 shares of Oric Pharmaceuticals worth $564K as of Q2 2026.
  • SG Americas Securities bought 35,996 Oric Pharmaceuticals shares in Q2 2026, an estimated $326K.
  • Oric Pharmaceuticals made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2245 holding.
  • SG Americas Securities first reported a position in Oric Pharmaceuticals in Q2 2020 and has held it in 13 quarters since.
  • SG Americas Securities's Oric Pharmaceuticals position peaked at $2.3M in Q3 2020.
  • 181 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.